Differing Amygdala Responses to Facial Expressions in Children and Adults With Bipolar Disorder
Publication: American Journal of Psychiatry
Abstract
Objective:
Child and adult bipolar patients show both behavioral deficits in face emotion processing and abnormal amygdala activation. However, amygdala function in pediatric relative to adult bipolar patients has not been compared directly. The authors used functional MRI to compare amygdala activity during a face processing task in children and adults with bipolar disorder and in healthy comparison subjects.
Method:
Amygdala responses to emotional facial expressions were examined in pediatric (N=18) and adult (N=17) bipolar patients and in healthy child (N=15) and adult (N=22) volunteers. Participants performed a gender identification task while viewing fearful, angry, and neutral faces.
Results:
In response to fearful faces, bipolar patients across age groups exhibited right amygdala hyperactivity relative to healthy volunteers. However, when responses to all facial expressions were combined, pediatric patients exhibited greater right amygdala activation than bipolar adults and healthy children.
Conclusions:
Amygdala hyperactivity in response to fearful faces is present in both youths and adults with bipolar disorder. However, compared with bipolar adults and healthy child volunteers, pediatric bipolar patients showed amygdala hyperactivity in response to a broad array of emotional faces. Thus, abnormal amygdala activation during face processing appears to be more pervasive in children than in adults with bipolar disorder. Longitudinal studies are needed to elucidate the mechanisms of this developmental difference, thus facilitating developmentally sensitive diagnosis and treatment.
Both children and adults with bipolar disorder exhibit deficits in face emotion processing and abnormalities in amygdala structure and activity (1–3). However, to our knowledge, no study has compared bipolar children and adults in amygdala activity during face emotion processing. Such a comparative study could facilitate developmentally sensitive diagnosis and treatment for bipolar disorder (4, 5). In this cross-sectional functional MRI (fMRI) study, our goal was to begin to fill this research gap.
Studies have reported behavioral deficits during explicit emotion processing (i.e., face emotion labeling) in children with bipolar disorder (6, 7), in unaffected children at risk for bipolar disorder (8), and in adults with bipolar disorder (1, 9). Neural abnormalities during explicit emotion processing have been observed in both bipolar children and adults (10). However, the most consistent evidence of neural abnormalities in emotion processing in children and adults with bipolar disorder is that of amygdala hyperactivity during implicit emotion processing. During such implicit tasks, emotional features are reflected in aspects of a stimulus, such as the display of emotion in a face, but task instructions focus on nonemotional features of the face, such as the gender of the person depicting the emotion. For example, using this type of implicit task, amygdala hyperactivity has been observed in bipolar children in response to fearful, angry, and happy faces (3, 11) and in bipolar adults in response to fearful, happy, and sad faces (12, 13). Thus, in the present study, we used a gender identification paradigm that involves implicit face emotion processing to test for abnormal amygdala activation in child and adult patients with bipolar disorder.
Evidence suggests that the course of bipolar disorder may be more severe in children than in adults (5, 14) and that younger patients may have greater impairment in face emotion perception than older patients (1). This in turn suggests that the neural circuitry mediating emotion information processing may be more impaired in youths than in adults with bipolar disorder. Indeed, recent meta-analyses have reported that decreased amygdala volume is observed more consistently in youths than in adults with the disorder (15, 16). However, these meta-analyses were based on separate structural studies of either youths or adults alone; studies that include both populations and employ identical procedures are needed. In fact, amygdala function in bipolar disorder has not been examined by applying identical methods to assess both adults and children. Such a study will initiate the process of identifying developmental trajectories of amygdala function in bipolar disorder to be pursued in future longitudinal work.
In this cross-sectional study, we compared amygdala activity in children and adults with bipolar disorder and in healthy comparison subjects during implicit processing of angry, fearful, and neutral facial expressions. We included only three facial expressions to ensure an adequate number of presentations of each stimulus type, thus maximizing statistical power while keeping the task brief enough to be tolerable for children. Fearful expressions were selected because they elicit amygdala hyperactivity consistently in both children and adults with bipolar disorder (3, 12). Angry and neutral expressions were included as a comparison negative emotion and a control stimulus, respectively. To compare neural activity in bipolar children and adults and comparison subjects of similar age, we conducted an amygdala region-of-interest and a whole-brain analysis.
Method
Participants
Bipolar children (ages 7–18 years) and adults (ages 19–60 years) were recruited through advertisements placed on support group websites and distributed to psychiatrists nationwide. Healthy child and adult volunteers were recruited by advertisement. No participants were biologically related.
The 72 participants included in this study were pediatric patients with bipolar disorder (N=18; age range: 9–18 years), adult patients with bipolar disorder (N=17; age range: 20–58 years), healthy child volunteers (N=15; age range: 12–17 years), and healthy adult volunteers (N=22; age range: 20–56 years). Participants enrolled in an institutional review board-approved protocol at the National Institute of Mental Health. Adult participants provided written informed consent. Parents and pediatric participants provided written informed consent and assent, respectively.
Pediatric patients were assessed with the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL) (17), which was administered separately to children and parents by clinicians with established interrater reliability (kappa ≥0.9). To evaluate mood state in bipolar children, clinicians administered the Children's Depression Rating Scale (18) and the Young Mania Rating Scale (19) within 48 hours of fMRI scanning. Pediatric patients met criteria for narrow phenotype bipolar disorder (20), with at least one full-duration hypomanic episode characterized by abnormally elevated mood and at least three DSM-IV-TR criterion B symptoms for mania. Adult patients were assessed with the Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (21) or the Diagnostic Interview for Genetic Studies (22) by clinicians with established interrater reliability (kappa ≥0.85). The Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (23), and Young Mania Rating Scale were used to evaluate mood state in adult patients.
Healthy volunteers were medication free and had no lifetime psychiatric diagnoses and no first-degree relatives with a mood disorder. They were assessed using the same diagnostic interviews as patients.
Inclusion criteria were an IQ >70 (as determined by the Wechsler Abbreviated Scale of Intelligence [24]) and no history of neurological disorder, pervasive developmental disorder, chronic medical illness, or substance abuse or dependence in the past 3 months. After fMRI scanning, 28 of the 100 scanned participants were excluded as a result of scanner malfunction (N=19), excessive movement (N=1), poor image alignment (N=1), or behavioral accuracy below 65% (N=7).
Behavioral Paradigm
The behavioral paradigm we employed has been used previously (25, 26). Participants viewed gray-scale images of fearful, angry, and neutral expressions of 10 men and 10 women from the Pictures of Facial Affect series (27). For fearful and angry faces, in addition to standard (100%) expression intensity, lower (50%) and higher (150%) expression intensities were created by morphing with the neutral expression picture. This was done to enhance ecological validity, since individuals normally encounter different face expression intensity levels (25). To create neutral faces, neutral and happy faces were morphed to obtain a 25% happy expression, since studies suggest that children (28) and adults (29) perceive such expressions as neutral.
Using a two-button response box, participants indicated whether the face presented was male or female. Faces were presented for 2500 msec followed by a 500-msec fixation cross. Each of the four runs included 80 face trials (20 neutral trials and 10 trials of each intensity of fearful and angry faces) and 25 fixation trials. The trial order was randomized within each run.
Image Acquisition
Scanning was conducted using a 1.5-T General Electric scanner (General Electric, Milwaukee). Functional data were acquired using multislice gradient echo-planar sequence (31 axial slices, 4-mm thick, voxel size=3.75 mm × 3.75 mm × 4 mm, TR=3000 msec, TE=30 msec, flip angle=90°, field of view=240 mm, matrix size=64×64). Anatomical T1-weighted three-dimensional spoiled gradient-recalled acquisition steady-state images with inversion recovery prep pulse (128 axial slices, 1.5 mm thick, TR=8.1 msec, TE=3.2 msec, flip angle=20°, field of view=240 mm, matrix size=256×256) were acquired to be coplanar with the fMRI scans for spatial registration.
Behavioral Data
We used SPSS (SPSS, Inc., Chicago) to conduct a three-way repeated-measures analysis of covariance (ANCOVA) with age group (child, adult) and diagnosis (bipolar disorder, healthy volunteer) as between-subject factors and emotion (fearful, angry, neutral) as a within-subject factor to compare accuracy and reaction time. Since there was a nearly significant difference in IQ between groups, IQ was included as a covariate. Post hoc ANCOVAs were performed using SPSS.
fMRI Data
Data preprocessing.
Functional imaging data were preprocessed and analyzed using AFNI (Analysis of Functional NeuroImages [30]). The first four images of each run were discarded to account for magnetic equilibrium. After slice time correction, images within each run were realigned to the fifth image to correct for movement. Images with motion greater than 2 mm in any direction were censored. If more than 5% of a participant's total images were censored, the participant was excluded. After motion correction, realigned functional images were coregistered to anatomical images, and functional images were anatomically normalized to Talairach space. Images were spatially smoothed with 6-mm root-mean-square deviation Gaussian blur.
At the individual participant level, general linear models were used to estimate the shape of the hemodynamic response to each event type (fearful, angry, and neutral expressions). To account for baseline drift and residual motion artifact, regressors included six motion parameters obtained during coregistration and a third-order baseline drift function. Regressors were created for each event type. Regressors for fearful and angry expressions were weighted according to emotional intensity (1 for 50%, 2 for 100%, and 3 for 150%). Trials with incorrect answers were analyzed separately by including a regressor that accounted for incorrect behavioral responses. All regressors were convolved with a gamma-variate hemodynamic response function. Beta coefficients from the individual participant level were oriented to the standard Talairach-Tournoux space and then resampled to a resolution of 3 mm3.
Region-of-interest analysis.
Anatomic masks of the right and left amygdala were created based on the Talairach-Tournoux Daemon. The masks were resampled to match their resolution to the fMRIs. Blood-oxygen-level-dependent (BOLD) signal change from each event type versus the fixation was averaged across all amygdala voxels and entered in SPSS for the group-level analysis. An omnibus three-way repeated-measures ANCOVA with age group (child, adult) and diagnosis (bipolar disorder, healthy volunteer) as between-subject factors and emotion (fearful, angry, neutral) as a within-subject factor was performed for the right and left amygdala. Since reaction time differed between groups, it was included as a covariate in addition to IQ. Post hoc univariate ANCOVAs were performed in SPSS to identify differences between groups.
Whole-brain analysis.
A group-level linear mixed-effects model was conducted with the 3dLME program in AFNI to examine between-group differences in response to the face emotions. The model included age group and diagnosis as between-subject factors and emotion as a within-subject factor, with IQ and reaction time as covariates. Using the 3dClustSim program in AFNI (http://afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html), Monte Carlo simulation (10,000 iterations, dimensions: 54×64×50 mm, 3×3×3 voxels, 9×9×8-mm smoothness) indicated that an initial voxel-wise threshold of p<0.001 and a minimum cluster size of 22 voxels yielded a corrected p value of 0.05. Post hoc univariate ANCOVAs were performed in SPSS to identify differences between groups and conditions.
Post hoc analyses.
We conducted post hoc exploratory univariate ANCOVAs in SPSS to test potentially confounding effects of mood state, medication treatment, comorbid illnesses, and bipolar disorder subtype on the region-of-interest results (see the data supplement accompanying the online edition of this article). Because these exploratory analyses included relatively small subsets of bipolar patients, we have provided significant results as well as those that fell short of statistical significance (p<0.10).
Results
Demographic and Clinical Characteristics
Within each age group, patients and healthy volunteers did not differ in mean age (Table 1). Between groups, participants did not differ in gender distribution. There was a nearly significant difference for higher IQ among adults relative to children (F=2.46, df=3, 68, p=0.07), and thus IQ was included as a covariate in all analyses.
| Bipolar Disorder Patients | Healthy Volunteers | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Pediatric (N=18) | Adult (N=17) | Pediatric (N=15) | Adult (N=22) | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||
| Age (years) | 14.29 | 2.54 | 40.04 | 10.06 | 14.98 | 2.03 | 34.91 | 12.27 | |
| Wechsler Abbreviated Scale of Intelligence full-scale IQ score | 107.83 | 13.83 | 114.53 | 12.71 | 108.27 | 15.35 | 118.05 | 15.51 | |
| Young Mania Rating Scale (YMRS) scorea | 6.83 | 3.73 | 3.77 | 4.55 | |||||
| Children's Depression Rating Scale (CDRS) scoreb | 26.53 | 7.41 | |||||||
| Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD) score | 17.47 | 15.59 | |||||||
| Age at onseta,c | 9.77 | 3.49 | 20.85 | 8.59 | |||||
| Number of medications | 2.83 | 1.89 | 3.00 | 1.06 | |||||
| N | % | N | % | N | % | N | % | ||
| Male | 10 | 55.6 | 5 | 29.4 | 5 | 33.3 | 9 | 40.9 | |
| Bipolar type | |||||||||
| Type I | 14 | 77.8 | 9 | 52.9 | |||||
| Type II | 4 | 22.2 | 8 | 47.1 | |||||
| Mood stated | |||||||||
| Euthymica | 15 | 83.3 | 9 | 52.9 | |||||
| Depresseda | 2 | 11.1 | 8 | 47.1 | |||||
| Hypomanic | 1 | 5.6 | 0 | 0 | |||||
| Manic | 0 | 0 | 0 | 0 | |||||
| Mixed | 0 | 0 | 0 | 0 | |||||
| Comorbid conditions | |||||||||
| Attention deficit hyperactivity disordera,e | 12 | 66.7 | 2 | 11.8 | |||||
| Oppositional defiant disorder | 3 | 16.7 | 0 | 0 | |||||
| Anxiety disordersf | 8 | 44.4 | 7 | 41.2 | |||||
| Medication | |||||||||
| Medication free | 3 | 16.7 | 0 | 0 | 15 | 100 | 22 | 100 | |
| Atypical antipsychotic | 11 | 61.1 | 8 | 47.1 | |||||
| Lithium | 6 | 33.3 | 5 | 29.4 | |||||
| Antiepileptica | 9 | 50.0 | 15 | 88.2 | |||||
| Antidepressant | 8 | 44.4 | 9 | 52.9 | |||||
| Stimulanta | 5 | 27.8 | 0 | 0 | |||||
a
Significant difference between adult and child patients with bipolar disorder.
b
Data were not available for one pediatric bipolar patient.
c Data were not available for one pediatric bipolar patient and one adult bipolar patient.
d
Euthymia in children was defined as a CDRS score <40 and a YMRS score ≤12 and in adults as a YMRS score ≤12 and a SIGH-SAD score ≤20. Depression in children was defined as a CDRS score >40 and a YMRS score ≤12 and in adults as a SIGH-SAD score >20 and a YMRS score ≤12. Hypomania/mania in children was defined as a CDRS score ≤40 and a YMRS score >12 and in adults as a SIGH-SAD score ≤20 and a YMRS score >12. Mixed state was defined as a SIGH-SAD score >20 and a YMRS score >12.
e Data were missing for three adult bipolar patients.
f
f Diagnoses include generalized anxiety disorder, separation anxiety disorder, social phobia, panic disorder, posttraumatic stress disorder, and obsessive-compulsive disorder.
Compared with adult patients, child patients were more likely to have an earlier age at illness onset (t=–4.93, df=31, p<0.001), to be euthymic (χ2=3.75, df=1, p=0.05), and to have higher Young Mania Rating Scale scores (t=3.70, df=33, p=0.001). Child patients had higher rates of attention deficit hyperactivity disorder (ADHD) (χ2=8.78, df=1, p=0.003) and stimulant treatment (χ2=5.51, df=1, p=0.02); they also had a higher rate of oppositional defiant disorder, although the difference fell short of statistical significance (χ2=3.10, df=1, p=0.08) (Table 1). Child patients were more likely to be medication free, although this difference also fell short of significance (χ2=3.10, df=1, p=0.08). Adult patients were more likely to be depressed (χ2=5.54, df=1, p=0.02) and to be receiving antiepileptic medication (χ2=5.93, df=1, p=0.02).
Behavioral Data
For accuracy in the faces task, no three- or two-way interaction was observed. The only main effect was that of age group (F=23.98, df=1, 67, p<0.001), indicating that children were less accurate in their responses than adults (Table 2). Since only correct trials were included in the fMRI analysis, accuracy was accounted for in the analysis of fMRI data.
| Bipolar Disorder Patients | Healthy Volunteers | |||||||
|---|---|---|---|---|---|---|---|---|
| Pediatric (N=18) | Adult (N=17) | Pediatric (N=15) | Adult (N=22) | |||||
| Variable and Event Type | Mean | SD | Mean | SD | Mean | SD | Mean | SD |
| Percent correcta | ||||||||
| Angry expressions | 86.05 | 10.13 | 95.67 | 3.33 | 90.92 | 8.82 | 96.00 | 3.20 |
| Fearful expressions | 86.07 | 9.23 | 98.23 | 1.87 | 91.49 | 9.51 | 97.89 | 2.57 |
| Neutral expressions | 87.39 | 11.50 | 98.27 | 1.79 | 93.25 | 7.45 | 98.26 | 1.83 |
| Reaction timeb | ||||||||
| Angry expressions | 933.94 | 110.46 | 788.85 | 127.67 | 843.52 | 152.43 | 749.14 | 86.91 |
| Fearful expressions | 932.26 | 112.78 | 780.10 | 127.18 | 830.77 | 161.30 | 749.14 | 87.31 |
| Neutral expressions | 935.19 | 119.55 | 760.77 | 121.09 | 827.35 | 154.40 | 739.73 | 91.83 |
a
There was a main effect of age group (F=23.98, df=1, 67, p<0.001).
b
There was a main effect of age group (F=13.63, df=1, 67, p<0.001) and of diagnosis (F=5.64, df=1, 67, p=0.02).
For reaction time, no three- or two-way interaction was observed. There were main effects of diagnosis (bipolar disorder patients were slower than healthy volunteers; F=5.64, df=1, 67, p=0.02) and age group (children were slower than adults; F=13.63, df=1, 67, p<0.001) (Table 2). Because of these between-group differences, reaction time was included as a covariate in the fMRI analyses.
fMRI Data
Region-of-interest analysis.
In the right amygdala (Figure 1), the age group-by-diagnosis-by-emotion interaction was not significant, but both two-way interactions achieved statistical significance (age group by diagnosis [F=4.30, df=1, 64, p=0.04]; diagnosis by emotion [F=4.52, df=2, 128, p=0.01]).
FIGURE 1. Region of Interest fMRI Results for Three- and Two-Way Interactions in the Right Amygdala in Pediatric and Adult Bipolar Patients and Healthy Child and Adult Volunteersa
a The age group-by-diagnosis and diagnosis-by-emotion interactions achieved statistical significance (p=0.04 and p=0.01, respectively), but the age group-by-diagnosis-by-emotion interaction did not.
A post hoc ANCOVA of the age group-by-diagnosis interaction revealed that across expressions, bipolar children exhibited greater amygdala activation than both bipolar adults (F=5.66, df=1, 29, p=0.02) and healthy children (F=8.99, df=1, 27, p=0.006), whereas no difference was observed for bipolar adults and healthy adults (Figure 2).
FIGURE 2. Age Group-by-Diagnosis Interaction in Pediatric and Adult Bipolar Patients and Healthy Child and Adult Volunteersa
a The graph depicts blood-oxygen-level-dependent (BOLD) responses across expressions in the right amygdala (F=4.30, df=1, 64, p=0.04). Error bars indicate standard deviations.
A post hoc ANCOVA of the emotion-by-diagnosis interaction revealed that bipolar patients had greater amygdala responses to fearful expressions than healthy volunteers (F=12.49, df=1, 68, p<0.001) (Figure 3). For angry and neutral expressions, amygdala activity did not differ between patients and healthy subjects.
FIGURE 3. Diagnosis-by-Emotion Interaction in Pediatric and Adult Bipolar Patients and Healthy Child and Adult Volunteersa
a The graph depicts blood-oxygen-level-dependent (BOLD) responses to fearful, angry, and neutral expressions across age groups in the right amygdala (F=4.52, df=2, 128, p=0.01). Error bars indicate standard deviations.
In the left amygdala, no significant interactions were observed. A main effect of age indicated that amygdala activation was greater among children than adults (F=7.75, df=1, 64, p=0.007).
Whole-brain analysis.
An age group-by-diagnosis-by-emotion interaction was observed in the left posterior cingulate cortex (F=12.34, df=2, 128; Montreal Neurological Institute coordinates: –7, –28, 38; 38 voxels, p<0.05 [corrected]). In the left posterior cingulate cortex, the age group-by-diagnosis interaction was observed only in response to angry expressions (F=4.61, df=1, 68, p=04). Specifically, bipolar children showed less activity in this region in response to angry expressions than healthy children (F=5.81, df=1, 31, p=02).
Effects of Mood State, Medication, Comorbid Illnesses, and Bipolar Subtype
Post hoc analyses examined whether the age group-by-diagnosis interaction in the right amygdala could be driven by differences between child and adult bipolar patients in mood state, in medication treatment, in comorbid illnesses, or in bipolar disorder subtype (see the online data supplement). The differences in this region between child and adult bipolar patients were either significant or fell just short of statistical significance after we controlled for most clinical differences (all p values <0.07). The exceptions were for differences in antiepileptic medication treatment and comorbid oppositional defiant disorder, for which confounding effects could not be ruled out.
Data indicate that relative to healthy volunteers, patients with anxiety disorders have amygdala hyperactivity in response to fearful faces (31). Therefore, we tested whether amygdala hyperactivity in bipolar patients in response to fearful faces, compared with healthy volunteers, could be a result of comorbid anxiety disorders. Bipolar patients without comorbid anxiety disorders showed greater amygdala activity (p=0.003) in response to fearful expressions than healthy volunteers.
Discussion
We compared amygdala activity in children and adults with bipolar disorder and healthy volunteers of similar age while they performed an implicit face emotion processing task that included fearful, angry, and neutral faces. Compared with healthy subjects, both children and adults with bipolar disorder exhibited amygdala hyperactivity in response to fearful expressions. However, compared with bipolar adults, children with the disorder exhibited amygdala abnormalities in response to a greater array of facial expressions. The results of this cross-sectional study suggest that there are potential developmental differences in amygdala activity in patients with bipolar disorder. Longitudinal studies are needed to test the hypothesis that amygdala abnormalities persist in response to fearful, but not angry and neutral, expressions as children with bipolar disorder age.
In response to fearful faces, both children and adults with bipolar disorder had increased right amygdala activity relative to healthy volunteers of similar age. This is consistent with results from previous studies that included only children or adults (3, 10, 12). However, in our study, when amygdala response was considered across all emotions (angry, neutral, and fearful expressions), pediatric bipolar patients exhibited amygdala hyperactivity relative to both bipolar adults and healthy children. Observation of amygdala hyperactivity across expressions in pediatric bipolar patients suggests that there is a more general form of face emotion dysfunction in pediatric bipolar disorder than in adult bipolar disorder. Such an observation is consistent with previous data, including behavioral results. A recent meta-analysis suggested that explicit face emotion processing deficits (i.e., deficits in face emotion labeling across expressions) are observed more consistently in youths than in adults with bipolar disorder (1). However, it is important to note that abnormalities in implicit and explicit emotion processing may not necessarily be linked (32). Thus, more fMRI studies are needed to understand the relevance of implicit processing deficits to behavioral explicit processing deficits as well as to examine brain activity during explicit emotion processing in both pediatric and adult patients with bipolar disorder.
Greater cumulative lifetime medication exposure in adult bipolar patients compared with pediatric patients may explain the amygdala activity differences between these two patient groups. In our study, the two groups did not differ on current rates of antidepressant and antipsychotic treatment. Nonetheless, cross-sectional research suggests that such medications may normalize amygdala activity in adults with bipolar disorder (33). Although to our knowledge this has not yet been tested, it is likely that cumulative exposure to medication may affect amygdala activity. In addition, the developmental differences in amygdala activity that we observed may be associated with differences in the clinical course between adults and youths with bipolar disorder. Although few studies have compared clinical course between the two groups directly, evidence suggests that pediatric bipolar patients may be more likely than adult patients to experience rapid cycling or mixed states (14). These clinical features, along with early age at onset, tend to be associated with poor longitudinal outcomes (14, 34). In our study, detailed information about mood cycling or global functioning was not available to test the hypothesis that amygdala hyperactivity across emotions may be linked with worse clinical outcome among pediatric relative to adult bipolar patients. However, this is an important issue for future research.
Our whole-brain analysis revealed that neural activity differences between pediatric and adult patients with bipolar disorder and between bipolar patients and healthy volunteers were not limited to the amygdala. Replicating a previously reported finding, children with bipolar disorder exhibited less activation in the left posterior cingulate cortex than healthy subjects in response to angry expressions (11). Studies have suggested that the posterior cingulate cortex is involved in top-down control of attention (35) and in integrating information about emotional expressions, particularly anger (36). Thus, the abnormal posterior cingulate cortex activity observed in pediatric bipolar patients may be associated with impaired attentional and information processing of angry expressions.
The limitations of this study include its cross-sectional design, since only longitudinal data can support firm conclusions about associations between development and brain activation in individuals with bipolar disorder. First, we cannot disambiguate two relevant hypotheses: 1) that abnormal amygdala activity in children with bipolar disorder becomes specific to fearful expressions as these children age and 2) that throughout a patient's life, pediatric-onset bipolar disorder is associated with more severe amygdala abnormalities than the adult-onset form of the disorder. While children and adults with bipolar disorder differed on some clinical characteristics, our post hoc exploratory analyses suggest that these variables largely did not account for the age-related differences we observed. Second, to ascertain whether differences in amygdala activity between bipolar patients and healthy volunteers represent dysfunction, rather than compensatory mechanisms in response to dysfunction in other brain regions, future studies should examine 1) associations among neural activity during emotional information processing, 2) behavior, and 3) clinical characteristics. For example, if amygdala hyperactivity in patients reflects amygdala dysfunction, one would expect elevated amygdala activity to be associated with behavioral deficits and poor clinical course. In contrast, if such hyperactivation is compensatory to dysfunction in other brain regions, one might expect elevated amygdala activity to predict relatively intact behavior and a relatively benign clinical course. Research examining the compensatory process ideally would follow children prospectively after acquisition of imaging data. In addition, while we were unable to identify aberrant activity in other brain regions to which amygdala hyperactivation might be compensatory, future studies examining larger samples, along with connectivity analyses, could be informative in that regard.
Our study provides the first evidence, to our knowledge, of age-related differences in amygdala activity in response to facial expressions among bipolar patients. Although bipolar disorder patients across age groups showed amygdala hyperactivity in response to fearful faces, the abnormal amygdala activation was present in response to more emotions in pediatric than in adult patients. These findings provide support and guidance for future longitudinal work examining the developmental trajectory of amygdala function, from the asymptomatic risk state through the course of the illness. Knowledge about this trajectory could help in the early detection of bipolar disorder and the development of age-appropriate treatments.
Acknowledgments
The authors thank the staff of the Emotion and Development Branch of NIMH and the children and families who participated in this study.
Footnote
Received Aug. 16, 2011; revision received Oct. 25, 2011; accepted Jan. 13, 2012.
Supplementary Material
Supplementary Materials and Table
- View/Download
- 239.58 KB
References
1.
Kohler CG, Hoffman LJ, Eastman LB, Healey K, Moberg PJ: Facial emotion perception in depression and bipolar disorder: a quantitative review. Psychiatry Res 2011; 188:303–309
2.
Chen CH, Suckling J, Lennox BR, Ooi C, Bullmore ET: A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord 2011; 13:1–15
3.
Kalmar JH, Wang F, Chepenik LG, Womer FY, Jones MM, Pittman B, Shah MP, Martin A, Constable RT, Blumberg HP: Relation between amygdala structure and function in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2009; 48:636–642
4.
Correll CU, Sheridan EM, DelBello MP: Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 2010; 12:116–141
5.
Axelson D, Birmaher B, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S, Bridge J, Keller M: Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 2006; 63:1139–1148
6.
Guyer AE, McClure EB, Adler AD, Brotman MA, Rich BA, Kimes AS, Pine DS, Ernst M, Leibenluft E: Specificity of facial expression labeling deficits in childhood psychopathology. J Child Psychol Psychiatry 2007; 48:863–871
7.
Rich BA, Vinton DT, Roberson-Nay R, Hommer RE, Berghorst LH, McClure EB, Fromm SJ, Pine DS, Leibenluft E: Limbic hyperactivation during processing of neutral facial expressions in children with bipolar disorder. Proc Natl Acad Sci USA 2006; 103:8900–8905
8.
Brotman MA, Guyer AE, Lawson ES, Horsey SE, Rich BA, Dickstein DP, Pine DS, Leibenluft E: Facial emotion labeling deficits in children and adolescents at risk for bipolar disorder. Am J Psychiatry 2008; 165:385–389
9.
Lembke A, Ketter TA: Impaired recognition of facial emotion in mania. Am J Psychiatry 2002; 159:302–304
10.
Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD: fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord 2000; 2:237–248
11.
Pavuluri MN, O'Connor MM, Harral E, Sweeney JA: Affective neural circuitry during facial emotion processing in pediatric bipolar disorder. Biol Psychiatry 2007; 62:158–167
12.
Lawrence NS, Williams AM, Surguladze S, Giampietro V, Brammer MJ, Andrew C, Frangou S, Ecker C, Phillips ML: Subcortical and ventral prefrontal cortical neural responses to facial expressions distinguish patients with bipolar disorder and major depression. Biol Psychiatry 2004; 55:578–587
13.
Blumberg HP, Donegan NH, Sanislow CA, Collins S, Lacadie C, Skudlarski P, Gueorguieva R, Fulbright RK, McGlashan TH, Gore JC, Krystal JH: Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology (Berl) 2005; 183:308–313
14.
Birmaher B, Axelson D, Goldstein B, Strober M, Gill MK, Hunt J, Houck P, Ha W, Iyengar S, Kim E, Yen S, Hower H, Esposito-Smythers C, Goldstein T, Ryan N, Keller M: Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry 2009; 166:795–804
15.
Usher J, Leucht S, Falkai P, Scherk H: Correlation between amygdala volume and age in bipolar disorder: a systematic review and meta-analysis of structural MRI studies. Psychiatry Res 2010; 182:1–8
16.
Pfeifer JC, Welge J, Strakowski SM, Adler CM, DelBello MP: Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2008; 47:1289–1298
17.
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36:980–988
18.
Poznanski EO, Cook SC, Carroll BJ: A depression rating scale for children. Pediatrics 1979, 64:442–450
19.
Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429–435
20.
Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS: Defining clinical phenotypes of juvenile mania. Am J Psychiatry 2003; 160:430–437
21.
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York, New York State Psychiatric Institute, Biometrics Research, 1995
22.
Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T: Diagnostic Interview for Genetic Studies: rationale, unique features, and training: NIMH Genetics Initiative. Arch Gen Psychiatry 1994; 51:849–859
23.
Williams JBW, Link MJ, Rosenthal NE, Terman M: Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders Version (SIGH-SAD). New York, New York Psychiatric Institute, 1988
24.
Weschler D: Weschler Abbreviated Scale of Intelligence. Austin, Tex, Psychological Corp, 1999
25.
Marsh AA, Finger EC, Mitchell DG, Reid ME, Sims C, Kosson DS, Towbin KE, Leibenluft E, Pine DS, Blair RJ: Reduced amygdala response to fearful expressions in children and adolescents with callous-unemotional traits and disruptive behavior disorders. Am J Psychiatry 2008; 165:712–720
26.
Blair K, Shaywitz J, Smith BW, Rhodes R, Geraci M, Jones M, McCaffrey D, Vythilingam M, Finger E, Mondillo K, Jacobs M, Charney DS, Blair RJ, Drevets WC, Pine DS: Response to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders. Am J Psychiatry 2008; 165:1193–1202
27.
Ekman P, Friesen W: Pictures of Facial Affect. Palo Alto, Calif, Consulting Psychologists, 1976
28.
Thomas KM, Drevets WC, Whalen PJ, Eccard CH, Dahl RE, Ryan ND, Casey BJ: Amygdala response to facial expressions in children and adults. Biol Psychiatry 2001; 49:309–316
29.
Phillips ML, Williams LM, Heining M, Herba CM, Russell T, Andrew C, Bullmore ET, Brammer MJ, Williams SC, Morgan M, Young AW, Gray JA: Differential neural responses to overt and covert presentations of facial expressions of fear and disgust. Neuroimage 2004; 21:1484–1496
30.
Cox RW: AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29:162–173
31.
Etkin A, Wager TD: Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164:1476–1488
32.
Lieberman MD, Eisenberger NI, Crockett MJ, Tom SM, Pfeifer JH, Way BM: Putting feelings into words: affect labeling disrupts amygdala activity in response to affective stimuli. Psychol Sci 2007; 18:421–428
33.
Phillips ML, Travis MJ, Fagiolini A, Kupfer DJ: Medication effects in neuroimaging studies of bipolar disorder. Am J Psychiatry 2008; 165:313–320
34.
Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, Ametrano RM, Wisniewski SR, Bowden CL, Thase ME, Nierenberg AA, Sachs G: Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord 2009; 11:391–400
35.
Small DM, Gitelman D, Simmons K, Bloise SM, Parrish T, Mesulam MM: Monetary incentives enhance processing in brain regions mediating top-down control of attention. Cereb Cortex 2005; 15:1855–1865
36.
Park JY, Gu BM, Kang DH, Shin YW, Choi CH, Lee JM, Kwon JS: Integration of cross-modal emotional information in the human brain: an fMRI study. Cortex 2010; 46:161–169
Information & Authors
Information
Published In
History
Received: 16 August 2011
Revision received: 25 October 2011
Accepted: 13 January 2012
Published online: 1 June 2012
Published in print: June 2012
Authors
Funding Information
Dr. Zarate is listed as a co-inventor on a patent application for the use of ketamine in major depression; he has assigned his rights in the patent to the U.S. government but will share a percentage of any royalties that may be received by the government. All other authors report no financial relationships with commercial interests.Supported by the Intramural Research Program of NIMH and NIH.
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).